FDA clears Medtronic’s catheter for use in the peripheral vascular system
The FDA cleared the TrailBlazer angled support catheter on Sept. 23 for use in the peripheral vascular system.
The catheter, which is manufactured by Medtronic, supports a guide wire during access to the peripheral arties and delivers solutions and diagnostic agents.
The TrailBlazer will be used in endovascular procedures treating complex peripheral artery disease, according to a company news release. The catheter features a stainless steel shaft and a 25- and 30-degree angled tip.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.